• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Pulmonology

Pulmonary arterial pruning and longitudinal change in percent emphysema and lung function

byBrian DoughertyandAlex Chan
February 24, 2021
in Pulmonology
Reading Time: 2 mins read
2 Minute Medicine Rewind May 20, 2019
Share on FacebookShare on Twitter

1. Among patients with and without COPD, a greater magnitude of pulmonary arterial pruning as measured by CT imaging was associated with a faster progression of percent emphysema as well as a faster decline in FEV1/FVC.

Evidence Level Rating: 2 (Good)

Chronic obstructive pulmonary disease (COPD), including emphysema, is a leading cause of morbidity and mortality worldwide. Additionally, a greater “percent emphysema,” or the percentage of emphysema-like lung measured on CT scan, is associated with greater lung function decline as well as mortality. It is unknown, however, if differences in pulmonary parenchymal vasculature contribute to the progression of emphysema and COPD. Therefore, this study sought to evaluate whether pulmonary artery “pruning” – as measured by the decrease in the ratio of small artery volume to the total pulmonary artery volume on CT imaging – is associated with a more rapid progression of percent emphysema and thus decline in lung function. 4,227 ever-smoking participants (mean [SD] age = 60 [9] years, 50% female) were included for analysis, 47% of whom were current smokers and 41% of whom had a diagnosis of COPD. Among study participants, median percent emphysema was 2.1% (IQR 0.6% to 6.3%). After adjusting for baseline percent emphysema and FEV1, it was found that greater pulmonary artery pruning was associated with a more rapid progression of percent emphysema (0.11% per year per SD arterial pruning, 95% CI 0.09 to 0.16) as measured by CT imaging. Pulmonary venous pruning also predicted a faster rate of percent emphysema progression, though to a lesser magnitude. Furthermore, arterial pruning was found to be associated with a faster decline in FEV1/FVC ratio (-0.04% per year per SD arterial pruning, 95% CI -0.008 to -0.001, p = 0.042), a spirometric classification used to determine the severity of airflow limitation. In all, this study suggests that greater pulmonary arterial pruning as seen on CT imaging is associated with a more rapid decline in lung function among patients with and without COPD, adding to prior data showing the importance of pulmonary vasculature in the pathogenesis and progression of emphysema and COPD.

Click to read the study in Chest

Image: PD

©2020 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

Artificial intelligence decision support software improved spirometry diagnosis performance in primary care

GSK and Hengrui Pharma Forge $500 Million China Collaboration, Including PDE3/4 Inhibitors

2 Minute Medicine: Pharma Roundup – Landmark lung approval, billion-dollar obesity drug deal, oncology safety halt, and GSK’s China push [August 14 2025]

Tags: copd
Previous Post

#VisualAbstract: Progression of COVID-19 reduced after high-titer convalescent plasma administration

Next Post

#VisualAbstract: CARG-BC score may predict risk of severe chemotherapy toxicity in elderly patients with early breast cancer

RelatedReports

Combination salmeterol-fluticasone therapy noninferior to fluticasone monotherapy for asthma events: The VESTRI trial
Artificial Intelligence

Artificial intelligence decision support software improved spirometry diagnosis performance in primary care

May 12, 2026
HOSPITAL score predicts risk of 30-day potentially avoidable readmission to hospital
Pharma

GSK and Hengrui Pharma Forge $500 Million China Collaboration, Including PDE3/4 Inhibitors

August 27, 2025
2 Minute Medicine: Pharma Roundup: Price Hikes, Breakthrough Approvals, Legal Showdowns, Biotech Expansion, and Europe’s Pricing Debate [May 12nd, 2025]
Pharma

2 Minute Medicine: Pharma Roundup – Landmark lung approval, billion-dollar obesity drug deal, oncology safety halt, and GSK’s China push [August 14 2025]

August 14, 2025
2 Minute Medicine Rewind May 20, 2019
Chronic Disease

Mepolizumab decreases exacerbations in patients with eosinophilic COPD

May 20, 2025
Next Post
#VisualAbstract: CARG-BC score may predict risk of severe chemotherapy toxicity in elderly patients with early breast cancer

#VisualAbstract: CARG-BC score may predict risk of severe chemotherapy toxicity in elderly patients with early breast cancer

Dacomitinib may be effective in EGFR-associated lung cancer

Cemiplimab monotherapy significantly improves outcomes in patients with advanced non-small-cell lung cancer with PD-L1 of at least 50%

#VisualAbstract: Progression of COVID-19 reduced after high-titer convalescent plasma administration

#VisualAbstract: Bimekizumab more efficacious than ustekinumab in treating severe plaque psoriasis

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Deep learning model improved cancer recurrence prediction for pediatric glioma using serial imaging
  • Brepocitinib becomes first oral therapy approved for adult dermatomyositis
  • An ultrasound-guided percutaneous method of vagal nerve stimulation may be effective for refractory chronic pain
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.